# A Study in Adults With Inflammatory Bowel Disease (IBD) Receiving Vedolizumab in the Patient Support Program (PSP) in Brazil

> **NCT05626088** · — · ACTIVE_NOT_RECRUITING · sponsor: **Takeda** · enrollment: 1006 (actual)

## Conditions studied

- Ulcerative Colitis
- Crohn's Disease

## Interventions

- **OTHER:** No Intervention

## Key facts

- **NCT ID:** NCT05626088
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-04-10
- **Primary completion:** 2024-12-27
- **Final completion:** 2026-05-29
- **Target enrollment:** 1006 (ACTUAL)
- **Last updated:** 2026-02-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05626088

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05626088, "A Study in Adults With Inflammatory Bowel Disease (IBD) Receiving Vedolizumab in the Patient Support Program (PSP) in Brazil". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT05626088. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*